8-K

Company

KIORA PHARMACEUTICALS INC

Filed

January 31, 2024

Period of Report

January 25, 2024

Accession Number

0001372514-24-000007

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →